Skip to main content

Advertisement

Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions

Fig. 4

Kaplan-Meier curve of 28-day mortality in patients with sepsis and septic shock. The curve is stratified by the optimal cut-off value of pentraxin 3 (a) and interleukin-6 (b) to predict septic shock (28-day mortality by pentraxin 3: 14.6% vs. 45.9%; 28-day mortality by interleukin-6: 5.1% vs. 49.1%)

Back to article page